|
Re: Courtesy
|
4
|
Resverlogix Corp.
|
Aug 22, 2017 04:31PM
|
|
Re: What would a successful BETonMACE Top-Line Data Announcement Look Like?
|
4
|
Resverlogix Corp.
|
Aug 12, 2019 05:20PM
|
|
Re: The thread has been killed
|
4
|
Resverlogix Corp.
|
Jun 12, 2019 04:18PM
|
|
Re: Bear
|
5
|
Resverlogix Corp.
|
Jul 19, 2020 11:28AM
|
|
Re: When in Rome.......
|
5
|
Resverlogix Corp.
|
Aug 27, 2016 04:15PM
|
|
All - I mean ALL - about the ASSURE trial
|
5
|
Resverlogix Corp.
|
Sep 15, 2017 03:19PM
|
|
REPROGRAM - trial with RVX208.
|
5
|
Resverlogix Corp.
|
Jul 13, 2020 04:23PM
|
|
mCRPC and BET inhibitors
|
5
|
Zenith Epigenetics
|
Jan 26, 2016 03:28PM
|
|
Re: Is this relevant to RVX
|
5
|
Resverlogix Corp.
|
May 17, 2020 11:21AM
|
|
Re: This week could be very telling....
|
5
|
Resverlogix Corp.
|
Sep 25, 2016 06:08AM
|
|
Re: From abstract 6 days ago: BRD inhibitors are promising candidates to prevent COVID-19 mediated cardiac damage
|
5
|
Resverlogix Corp.
|
Oct 21, 2020 02:28PM
|
|
Re: HL
|
5
|
Resverlogix Corp.
|
Nov 17, 2017 03:34PM
|
|
Re: BETonMACE Cognition Sub-Study Published
|
5
|
Resverlogix Corp.
|
Sep 01, 2021 12:26PM
|
|
Re: Last pull back we bounced off the 12 DMA....
|
5
|
Resverlogix Corp.
|
Oct 11, 2016 12:57PM
|
|
Re: Technicals have looked good before....
|
5
|
Resverlogix Corp.
|
Sep 01, 2016 03:41PM
|
|
Re: Friedreich’s Ataxia Therapy News - Very interesting
|
6
|
Resverlogix Corp.
|
May 26, 2017 08:37AM
|
|
Re: ... a couple things...
|
6
|
Resverlogix Corp.
|
May 09, 2018 05:48PM
|
|
Re: Friedreich’s Ataxia Therapy News - Very interesting
|
6
|
Resverlogix Corp.
|
May 26, 2017 09:18AM
|
|
Re: RVX rises above 200-day moving average
|
6
|
Resverlogix Corp.
|
Sep 21, 2020 03:26PM
|
|
Re: Novartis Phase III study shows Canakinumab reduces MACE events
|
6
|
Resverlogix Corp.
|
Jun 22, 2017 02:12PM
|
